Clinical Trial: ECOG-ACRIN EA7222

ECOG-ACRIN EA7222

Status: New, Open

A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas

Eligible for screening study DCP 001